AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $76.42M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| TKM | Amendment to option agreement for divestment of Hendeka | 04/02/25 | ||
| TKM | Share Sale Agreement Signed to purchase Kroussou Project | PRICE SENSITIVE | 28/03/18 | |
| TKM | Kroussou Mapping & Geophyscs | PRICE SENSITIVE | 22/02/18 | |
| TKM | Investor Presentation | 05/02/18 | ||
| TKM Amendment to option agreement for divestment of Hendeka | |||
| 04/02/25 | |||
| TKM Share Sale Agreement Signed to purchase Kroussou Project | |||
| 28/03/18 | PRICE SENSITIVE | ||
| TKM Kroussou Mapping & Geophyscs | |||
| 22/02/18 | PRICE SENSITIVE | ||
| TKM Investor Presentation | |||
| 05/02/18 | |||
